Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: A pilot study;Obecność przeciwciał przeciw Chlamydia pneumoniae wśród irańskich chorych na stwardnienie rozsiane: Badanie pilotażowe

Neurologia i Neurochirurgia Polska

Volumn 45, Issue 2, 2011, Pages 128-131

  Aghaei, Maryam ^a   Ashtari, Fereshteh ^b   Bahar, Mohammadali ^c   Falahian, Mohammad Reza ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chlamydia pneumoniae; ELISA; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PILOT STUDY;

EID: 79958243349     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60023-2     Document Type: Article

References (22)

1. Hosking M.P., Lane T.E. The biology of persistent infection: inflammation and demyelination following murine coronavirus infection of the central nervous system. Curr Immunol Rev 2009; 5: 267-276.
2. Szczucinski A., Losy J. Infectious agents in the pathogenesis of multiple sclerosis. Przegl Epidemiol 2006; 60 (Suppl 1): 160-165.
3. Bagert B.A. Epstein-Barr virus in multiple sclerosis. Curr Neurol Neurosci Rep 2009; 9: 405-410.
4. Herndon R.M. Herpesviruses in multiple sclerosis. Arch Neurol 1996; 53: 123-124.
5. Sargsyan S.A., Shearer A.J., Ritchie A.M., et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010; 74: 1127-1135.
6. Sriram S., Stratton C.W., Yao S., et al. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46: 6-14.
7. Contini C., Seraceni S., Cultrera R., et al. Chlamydophila pneumoniae infection and its role in neurological disorders. Interdiscip Perspect Infect Dis 2010; 2010: 273573.
8. Ikejima H., Friedman H., Yamamoto Y. Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease. J Med Microbiol 2006; 55: 947-952.
9. Balin B.J., Little C.S., Hammond C.J., et al. Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimer Dis 2008; 13: 371-380.
10. Njamnshi A.K., Blackett K.N., Mbuagbaw J.N., et al. Chronic Chlamydia pneumoniae infection and stroke in Cameroon: a case-control study. Stroke 2006; 37: 796-799.
11. Fainardi E., Castellazzi M., Seraceni S., et al. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 2008; 5: 60-70.
12. Etemadifar M., Janghorbani M., Shaygannejad V., et al. Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006; 27: 39-44.
13. Al Araji A., Mohammed A.I. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 2005; 234: 67-71.
14. Moreira M.A., Felipe E., Mendes M. F, et al. Multiple sclerosis: descriptive study of its clinical forms in 302 cases. Arq Neuropsiquiatr 2000; 58: 460-466.
15. Orton S.M., Herrera B.M., Yee I.M., et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5: 932-936.
16. Wasay M., Ali S., Khatri I.A., et al. Multiple sclerosis in Pakistan. Mult Scler 2007; 13: 668-669.
17. Kalayoglu M.V., Libby P, Byrne G.I. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002; 288: 2724-2731.
18. Bandaru VC., Boddu D.B., Laxmi V., et al. Seroprevalence of Chlamydia pneumoniae antibodies in stroke in young. Can J Neurol Sci 2009; 36: 725-730.
19. Boelen E., Steinbusch H.W., van der Ven A.J., et al. Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging 2007; 28: 524-532.
20. Munger K.L., DeLorenze G.N., Levin L.I., et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology 2004; 62: 1799-1803.
21. Franciotta D., Zardini E., Bergamaschi R., et al. Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases. Acta Neurol Scand 2005; 112: 238-241.
22. Parratt J., Tavendale R., O'Riordan J., et al. Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis. Mult Scler 2008; 14: 292-299.